Use access key #2 to skip to page content.
$32.15 1.52 (4.96%)
5/16/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar srothstein (69.02) Submitted: 5/09/08 3:58 PM : Outperform Start Price: $28.48 AMLN Score: 10.19

New Drug In Pipeline.

Report this Post Replies: 0 | Reply

Featured Broker Partners